Join the club for FREE to access the whole archive and other member benefits.

ReNeuron

Company focused on the research, development, and commercial exploitation of stem cell technologies

We are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.

We have used our unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered “off-the-shelf” to any eligible patient without the need for additional drug treatments.

We are also progressing development of our exosomes platform, focusing on its use as a novel vector for delivering third party drugs. Exosomes are nano-sized particles that facilitate the communication between cells through the transfer of biologically active molecules such as proteins and nucleic acids (RNA and DNA). Large numbers of exosomes are secreted into the culture media during the expansion of our stem cells. Following purification, these natural delivery vehicles can be modified or ‘loaded’ with complex, hard-to-deliver therapeutic agents to specific areas of the body.

Visit website: http://www.reneuron.com/

 reneuron

Details last updated 03-Oct-2019

ReNeuron News

Advances in stem cell cures by new biotech startups

GEN News - 03-Nov-2020

New generation companies develop novel cell therapies using stem cells

Read more...
Topics mentioned on this page:
Stem Cells